Related Experiment Video
Updated: Jul 2, 2026

A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side
Published on: May 6, 2016
The pyroptosis cascade between inflammatory endothelial cells and microglia facilitates BBB disruption in bacterial
Yangyang Zheng1, Zhiyue Wu1, Fei Wu1
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China; Tianjin Institutes of Health Science, Tianjin 301600, China.
Abstract:
Neonatal meningitis-causing Escherichia coli (NMEC) is a primary etiological agent of neonatal meningitis. Inflammatory cell death triggered by NMEC infection has been implicated as a critical determinant of blood-brain barrier (BBB) disruption and neuroinflammation. However, the mechanisms underlying inflammatory BBB breakdown and the propagation of inflammation within the neuroinflammatory milieu remain poorly understood. Here, we show that brain endothelial cells (ECs) undergo GSDMD-dependent pyroptosis in response to NMEC infection. Through integrated spatiotemporal single-cell transcriptomic, epigenomic, and proteomic analyses, we identify Gbp5 as a key regulator of pyroptosis in brain ECs. Moreover, we uncovered a homeostasis-to-inflammation transition in both ECs and microglia (MG), whereby pyroptotic ECs promote microglial pyroptosis via Angptl4-Sdc4 signaling. This intercellular communication establishes a "pyroptosis cascade" between BBB ECs and microglia in the central nervous system (CNS), providing mechanistic insight into inflammatory BBB disruption and revealing potential therapeutic targets within the CNS immune microenvironment.
Insights
Neonatal meningitis-causing Escherichia coli triggers brain endothelial cell pyroptosis, leading to blood-brain barrier disruption. This study identifies a pyroptosis cascade involving microglia, offering new therapeutic targets for meningitis.
Area of Science:
- Neuroscience
- Immunology
- Microbiology
Background:
- Neonatal meningitis-causing Escherichia coli (NMEC) is a major cause of neonatal meningitis.
- NMEC infection induces inflammatory cell death, crucial for blood-brain barrier (BBB) disruption and neuroinflammation.
- Mechanisms of BBB breakdown and inflammation propagation in the CNS remain unclear.
Purpose of the Study:
- To elucidate the mechanisms of NMEC-induced BBB disruption and neuroinflammation.
- To identify key regulators of inflammatory cell death in brain endothelial cells (ECs).
- To uncover intercellular communication pathways driving the neuroinflammatory cascade.
Main Methods:
- Integrated spatiotemporal single-cell transcriptomic, epigenomic, and proteomic analyses.
- Investigation of GSDMD-dependent pyroptosis in brain ECs following NMEC infection.
- Analysis of intercellular signaling between ECs and microglia (MG).
Main Results:
- Brain ECs undergo GSDMD-dependent pyroptosis upon NMEC infection.
- Gbp5 was identified as a critical regulator of pyroptosis in brain ECs.
- A pyroptosis cascade was uncovered, where pyroptotic ECs promote microglial pyroptosis via Angptl4-Sdc4 signaling.
Conclusions:
- NMEC infection triggers a pyroptosis cascade between brain ECs and microglia.
- This cascade contributes to BBB disruption and neuroinflammation in the CNS.
- The identified signaling pathway presents potential therapeutic targets for neonatal meningitis.
More Related Videos
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
09:35Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells
Published on: May 19, 2020
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis
Bacterial Meningitis I: Introduction
Encephalitis ll: Pathophysiology
Viral Meningitis
Acute Inflammation II: Cellular Phase